Retrospective Study of Clinical Practice and Management of Imported Schistosomiasis in France

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04810741

Acronym

RETROBIZH

Enrollment

532

Registered

2021-03-23

Start date

2021-12-21

Completion date

2022-05-18

Last updated

2023-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schistosomiasis

Keywords

schistosomiasis, retrospective

Brief summary

Detailed description

Schistosomiasis is a major public health issue. Clinical guidelines for the management of imported schistosomiasis are heterogeneous. The objective of this study is to describe the clinical management of schistosomiasis imported cases in France, regarding diagnosis, treatment and follow-up. It is a multicentric, retrospective, descriptive study. Inclusion criteria are an age ≥ 18, a positive western blot and / or a positive microscopy exam. Data concerning clinical presentation, biological samples, imaging, treatment and follow-up will be assessed. A descriptive analysis will be performed.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥ 18, positive schistosomiasis immunoblot and / or positive microscopy examination for schistosomiasis eggs

Exclusion criteria

* \- patients under guardianship

Design outcomes

Primary

Measure	Time frame	Description
Describe the management of patients with chronic schistosomiasis in France, in terms of diagnosis, assessment, management and follow-up.	12 months	Draft of new clarified recommendations on the overall management of this pathology

Countries

France

Outcome results